TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,952 | -66.3% | 353 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $8,769 | +65.1% | 353 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $5,310 | +27.2% | 353 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,176 | +108.8% | 353 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 353 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | -33.3% | 353 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | -57.1% | 353 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $7,000 | -41.7% | 353 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $12,000 | -14.3% | 353 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | -17.6% | 353 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $17,000 | +70.0% | 353 | +81.0% | 0.00% | +33.3% |
| Q4 2020 | $10,000 | +100.0% | 195 | 0.0% | 0.00% | +200.0% |
| Q3 2020 | $5,000 | +25.0% | 195 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | +100.0% | 195 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |